about the author

Ana Mulero

info@raps.org

author articles

FDA to roll out mod­ern­iza­tion plan in push for da­ta in­ter­op­er­abil­i­ty

5 years ago
FDA+

FDA so­lic­its in­dus­try in­put for OND pol­i­cy pri­or­i­ties

5 years ago
FDA+

FDA, EMA ad­vise on risk-based mon­i­tor­ing in clin­i­cal tri­als

5 years ago
FDA+

CDER drafts drug de­vel­op­ment guid­ance on NASH with com­pen­sat­ed cir­rho­sis

5 years ago
FDA+

Got­tlieb tes­ti­fies on sta­tus of FDA op­er­a­tions af­ter gov­ern­ment shut­down

6 years ago
Pharma

FDA works to re­duce dog test­ing in drug de­vel­op­ment

6 years ago
Pharma

FDA lists 205 mol­e­c­u­lar tar­gets for pe­di­atric can­cer re­search

6 years ago
R&D
Pharma

Law­mak­ers halt push for drug prices in TV ads

6 years ago
Pharma

FDA launch­es pi­lot pro­gram in sup­port of com­plex tri­al de­signs for drugs and bi­o­log­ics

6 years ago
Pharma
A service from the Financial Times